Acoltzin C, Rabling E

Language: Spanish
References: 24
Page: 3-6
PDF size: 215.26 Kb.

ABSTRACT

Introduction and objetives: The prolongation of ventricular M cell action potential lengthens QT, increases the supernormal phase and propitiates death by electrocution; however, it is not possible to identify the patient who is at risk. Because the descending branch of the T–wave in the area principally affected, the possibility of arrythmogenic risk could be identified by the relative duration of the T descending branch is worth considering. Material and methods: Electrocardiograms of patients in sinusal rhythm, with a cardiac frequency between 60 and 100 p/m, QRS lower than 0.100 s. and without myocardial infarction o medication affecting repolarization were analyzed. The R-R, QT, QRS and the descending branch of the T-wave (rdT) were measured. QRS was subtracted from QT (JT), rdT was divided by JT and multiplied by 100. QTc was calculated. Groups were separated according to QTc duration between 0.350 and 0.440 o greater (QTc N and QTc L). Histograms were made. Mean, standard deviation, median, mode and interquartile range were calculated. Data was analyzed using the Mann-Withney U test and the Z transformation of the normal curve. Result: There were 100 electrocardiograms of QTc L and 400 of QTc N. The curves were non-parametric with downward bias. There was significant difference (p = 0.002). The interquartile range was similar in 75% of the cases. Z transformation indicated abnormality in rdT/JT = 44. Conclusion: The descending branch of T bigger than 44% of JT is abnormal.

REFERENCES

1. Sandøe E, Sigurd B. Arrhythmia. Diagnosis and management: a clinical electrocardiographic guide. Copenhagen, Fachmed AG Verlang für Fachmedien. 1984: 182-189.

2. Zareba W, Schwartz PJ, Vincent GM et al. Influence of genotype on the clinical course of the long-QT syndrome: international long-QT syndrome register research group. N Engl J Med. 1998; 229: 960-965.

3. Priori SG, Napolitano G, Bloise R et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003; 348: 1866-1874.

4. Priori SG, Corr PB. Mechanisms underlying early and delayed after despolarizations induced by catecholamines in isolated adult ventricular myocites. Am J Physiol. 1990; 252: H1796-H1805.

5. Zhang Li, Vincent GM, Lehmann MH et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndromes: ECG findings identify genotypes. Circulation. 2000; 102: 2849-2855.

6. Al-Khatib SM, Sanders GD, Bigger JT et al. Preventing tomorrow’s sudden cardiac death today. Part I: Current data on risk stratification for sudden cardiac death. Am Heart J. 2007; 153: 941–950.

7. Vrtovec B, Fister M, Poglajen G et al. Diabetes does not affect ventricular repolarization and sudden cardiac death. Pacing Clin Electrophysiol. 2009; 32: S146-S150.

8. Lin Y, Lin L, Chen Y et al. The association between T-wave morphology and life-threatening ventricular tachyarrhythmias in patients with congestive heart failure. Pacing Clin Electrophysiol. 2009; 32: 1173-1177.

9. Lown BM. Approaches to sudden death from coronary heart disease. Circulation. 1971; 44: 130.

10. Lüderitz B. Terapia de las alteraciones del ritmo cardiaco. Guía para clínica y consultorio. España: Editorial Reverte S.A.; 1982. pp. 1-14.

11. Shimizu W, Antzelevitch Ch. Cellular basis for the ECG features of the LQT1 from of the long-QT syndrome. Effects of β-adrenergic agonists and antagonists and sodium channel blockers en transmural dispersion of the repolarization and torsade de pointes. Circulation. 1998; 98: 2314-2322.

12. Schwartz P. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004; 109: 1826-1833.

13. Pappachan JM, Sebastian J, Bino BC et al. Cardiac autonomic neuropathy in diabetic mellitus; prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad Med J. 2008; 84: 205-210.

14. Yan GX, Antzelevitch Ch. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation. 1998; 98: 1928-1936.

15. Mendenhall W, Scheaffer RL, Wackerly DD. Estadística matemática con aplicaciones. México: Grupo Editorial Iberoamérica, S.A. de C.V.; 1986. pp. 388-399.

16. Day CP, Campbell RW. QT dispersion: an indication of the arrhythmia risk in patients with long QT-intervals. Br Heart J. 1990; 63: 342-344.

17. Priori SG, Diehl L, Schwartz PJ. Dispersion of the QT interval. A marker of the therapeutic efficacy in the idiophatic long-QT syndrome. Circulation. 1994; 893: 1681-1690.

18. Moss AJ, Kaufman ES, Gartman E et al. Increased risk of arrhythmic events in the long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potasium chanel. Circulation. 2002; 105: 794-799.

19. Kilicaslan F, Tokatli A, Ozdag F et al. Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio are prolonged in patients with moderate and severe obstructive sleep apnea. Pacing Clin Electrophysiol. 2012; 35 (8): 966-972.

20. Couderc JP, Xia X, Peterson DR et al. T-wave morphology abnormalities in benign, potent, and arrhythmogenic I-kr inhibition. Heart Rhythm. 2011; 8 (7): 1036-1043.

21. Cygankiewics I, Zareba W, Vázquez R et al. Prognostic value of QT/RR slope in predicting mortality in patients with congestive heart failure. J Cardiovasc Electrophisiology. 2008; 19 (10): 1066-1072.

22. Smetana P, Schmidt A, Zabel M et al. Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization components. J Electrocardiol. 2011; 44 (3): 301-308.

23. Erikssen J, Liestøl K, Gullestad L et al. The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction. Ann Noninvasive Electrocardiol. 2012; 17 (2): 85-94.

24. Haapalahti P, Viitasolo M, Vaananen H et al. Electrocardiographic ventricular repolarization during cardiovascular autonomic function in patients with arrythmogenic right ventricular cardiomyopathy. Scand Cardiovasc J. 2008; 42: 375-382.